http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014513930-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04 |
| filingDate | 2012-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2014513930-A |
| titleOfInvention | FGFR and its ligand as biomarkers of breast cancer in HR positive subjects |
| abstract | The present invention is a method for diagnosis, treatment and prognosis of a breast cancer HR + patient, wherein the subject comprises one or more biologics comprising FGFR ligands such as FGF3, FGF4, FGF19 and / or FGFR, such as FGFR1. Detecting amplification of the marker and determining an FGFR1 inhibitor for treating the subject based on the amplification of the one or more biomarkers in the subject and administering the FGFR1 inhibitor to the subject in need thereof And using the one or more biomarkers indicative of the prognosis of a subject treated with the FGFR1 inhibitor. |
| priorityDate | 2011-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 124.